EDX Medical to Present at Hardman & Co Investor Forum

Hardman & Co Research has announced that EDX Medical will participate in an upcoming Investor Forum. The event is scheduled for 14 November 2024 at 3:00 pm. EDX Medical, listed on the AQSE Growth Market's Apex Segment, focuses on medical diagnostics. Founded by Professor Sir Christopher Evans and led by CEO Dr. Mike Hudson, the company aims to improve disease detection and treatment strategies using advanced technologies.

This online session will address growth strategies and the implications of recent economic measures. It offers a platform for businesses to discuss sustaining and driving growth. Investors are invited to attend and engage with presenters in a Q&A session. The webinar is free, and a recording will be available afterwards for those unable to attend live.